Expression of cluster of differentiation 9 glycoprotein in benign and malignant parotid gland tumours

被引:1
作者
Sakamoto, K. [1 ]
Ono, T. [1 ]
Nakamura, Y. [3 ]
Harada, H. [2 ]
Nakashima, T. [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kurume, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan
[3] St Marys Hosp, Dept Pathol, Kurume, Fukuoka, Japan
关键词
Parotid Gland Tumors; CD9; Immunohistochemistry; DIPHTHERIA-TOXIN RECEPTOR; MEMBRANE-PROTEIN; GROWTH-FACTOR; MONOCLONAL-ANTIBODY; POOR-PROGNOSIS; WARTHINS TUMOR; CELL-ADHESION; CD9; MOTILITY; BINDING;
D O I
10.1017/S0022215109005106
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: This study aimed to clarify the significance of cluster of differentiation 9 glycoprotein gene expression in human parotid gland tumours. Methods: We retrospectively analysed immunohistochemical staining for cluster of differentiation 9 glycoprotein in parotid gland tumours. Results: Cluster of differentiation 9 glycoprotein was consistently detected in the normal parotid gland. Regarding benign parotid gland tumours, cluster of differentiation 9 glycoprotein was present in 13 of 18 pleomorphic adenomas, in all Warthin tumours tested (21/21) and in all cases of basal cell adenoma tested (four of four). In contrast. positive staining for cluster of differentiation 9 glycoprotein was less often observed in malignant parotid tumours. Cluster of differentiation 9 glycoprotein was present in 11 of 14 mucoepidermoid carcinomas, in two of five acinic cell carcinomas and in two of five adenoid cystic carcinomas. Conclusions: There was a statistically significantly reduced expression of cluster of differentiation 9 glycoprotein in malignant parotid gland tumours, compared with benign parotid gland tumours (p < 0.05). These results suggest that a low level of cluster of differentiation 9 glycoprotein expression in parotid gland tumours may be associated with malignancy.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 20 条
[1]   THE ROLE OF INTEGRINS ALPHA-2-BETA-1 AND ALPHA-3-BETA-1 IN CELL CELL AND CELL SUBSTRATE ADHESION OF HUMAN EPIDERMAL-CELLS [J].
CARTER, WG ;
WAYNER, EA ;
BOUCHARD, TS ;
KAUR, P .
JOURNAL OF CELL BIOLOGY, 1990, 110 (04) :1387-1404
[2]   KAI1, A METASTASIS SUPPRESSOR GENE FOR PROSTATE-CANCER ON HUMAN-CHROMOSOME 11P11.2 [J].
DONG, JT ;
LAMB, PW ;
RINKERSCHAEFFER, CW ;
VUKANOVIC, J ;
ICHIKAWA, T ;
ISAACS, JT ;
BARRETT, JC .
SCIENCE, 1995, 268 (5212) :884-886
[3]  
HIGASHIYAMA M, 1995, CANCER RES, V55, P6040
[4]   THE MEMBRANE-PROTEIN CDB/DRAP-27 POTENTIATES THE JUXTACRINE GROWTH-FACTOR ACTIVITY OF THE MEMBRANE-ANCHORED HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR [J].
HIGASHIYAMA, S ;
IWAMOTO, R ;
GOISHI, K ;
RAAB, G ;
TANIGUCHI, N ;
KLAGSBRUN, M ;
MEKADA, E .
JOURNAL OF CELL BIOLOGY, 1995, 128 (05) :929-938
[5]   NOVEL STRUCTURALLY DISTINCT FAMILY OF LEUKOCYTE SURFACE GLYCOPROTEINS INCLUDING CD9, CD37, CD53 AND CD63 [J].
HOREJSI, V ;
VLCEK, C .
FEBS LETTERS, 1991, 288 (1-2) :1-4
[6]  
HOTTA H, 1988, CANCER RES, V48, P2955
[7]   SUPPRESSION OF CELL MOTILITY AND METASTASIS BY TRANSFECTION WITH HUMAN MOTILITY-RELATED PROTEIN (MRP-1/CD9) DNA [J].
IKEYAMA, S ;
KOYAMA, M ;
YAMAOKO, M ;
SASADA, R ;
MIYAKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1231-1237
[8]   HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR, WHICH ACTS AS THE DIPHTHERIA-TOXIN RECEPTOR, FORMS A COMPLEX WITH MEMBRANE-PROTEIN DRAP27/CD9, WHICH UP-REGULATES FUNCTIONAL RECEPTORS AND DIPHTHERIA-TOXIN SENSITIVITY [J].
IWAMOTO, R ;
HIGASHIYAMA, S ;
MITAMURA, T ;
TANIGUCHI, N ;
KLAGSBRUN, M ;
MEKADA, E .
EMBO JOURNAL, 1994, 13 (10) :2322-2330
[9]  
IWAMOTO R, 1991, J BIOL CHEM, V266, P20463
[10]   P24 - A HUMAN LEUKEMIA-ASSOCIATED AND LYMPHOHEMOPOIETIC PROGENITOR CELL-SURFACE STRUCTURE IDENTIFIED WITH MONOCLONAL-ANTIBODY [J].
KERSEY, JH ;
LEBIEN, TW ;
ABRAMSON, CS ;
NEWMAN, R ;
SUTHERLAND, R ;
GREAVES, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (03) :726-731